Research map: Comparative effectiveness of azithromycin versus roflumilast in patients with chronic obstructive pulmonary disease: emulated target trial

Papers in this map

1. Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease · TERENCE A. R. SEEMUNGAL · 1998 · 2343 citations · Cited by this paper
2. Healthcare must be built around patients, not profits · Tom Moberly · 2026 · Cites this paper
3. Medical colleges developing successor to axed NHS training scheme for overseas doctors · 2026 · Related
4. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease · Gavin C. Donaldson · 2002 · 2304 citations · Cited by this paper
5. Does Mounjaro cause hair loss? · 2026 · Related
6. Azithromycin for Prevention of Exacerbations of COPD · Richard K Albert · 2011 · 1228 citations · Cited by this paper
7. Palantir tool has not cut delayed discharges at NHS trusts, study finds · 2026 · Related
8. High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data · Sebastian Schneeweiß · 2009 · 1166 citations · Cited by this paper
9. Brain gain, waste, strain, and drain: international medical graduates after UK medical training legislation · 2026 · Related
10. Target Trial Emulation · Miguel Ángel Hernán · 2022 · 975 citations · Cited by this paper
11. Four fifths of NHS trusts are still using pen and paper for record keeping, 25 years after first digitisation push · 2026 · Related
12. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials · Peter M.A. Calverley · 2009 · 830 citations · Cited by this paper
13. Ectopic pregnancy: Rise in admissions may be linked to deprivation, study suggests · 2026 · Related
14. Identifying Individuals with Physcian Diagnosed COPD in Health Administrative Databases · Andrea S. Gershon · 2009 · 677 citations · Cited by this paper
15. Fossil fuel industry has no place at climate COP · 2026 · Related
16. Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts · Surya Prakash Bhatt · 2023 · 521 citations · Cited by this paper
17. Private equity involvement in UK healthcare · 2026 · Related
18. Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses · Shirley V. Wang · 2023 · 416 citations · Cited by this paper
19. Digitisation of primary care excludes those in greatest need · 2026 · Related
20. Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial · Fernando J. Martínez · 2015 · 372 citations · Cited by this paper
21. Pio Mangion · 2026 · Related
22. Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation · Surya Prakash Bhatt · 2024 · 295 citations · Cited by this paper
23. Transparent Reporting of Observational Studies Emulating a Target Trial—The TARGET Statement · Aidan Gregory Cashin · 2025 · 235 citations · Cited by this paper
24. Validation of the Recording of Acute Exacerbations of COPD in UK Primary Care Electronic Healthcare Records · Kieran Rothnie · 2016 · 173 citations · Cited by this paper
25. Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype · Frank C. Sciurba · 2025 · 160 citations · Cited by this paper
26. The Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Diagnosis Codes for Identifying Patients Hospitalized for COPD Exacerbations · Brian D. Stein · 2011 · 151 citations · Cited by this paper
27. Role of macrolide therapy in chronic obstructive pulmonary disease · Fernando J. Martínez · 2008 · 122 citations · Cited by this paper
28. Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions · Shirley V. Wang · 2022 · 121 citations · Cited by this paper
29. Using high‐dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system · Jeremy A. Rassen · 2012 · 104 citations · Cited by this paper
30. Meta-Analysis of the Adverse Effects of Long-Term Azithromycin Use in Patients with Chronic Lung Diseases · Hui Li · 2013 · 98 citations · Cited by this paper
31. Automated data-adaptive analytics for electronic healthcare data to study causal treatment effects · Sebastian Schneeweiß · 2018 · 90 citations · Cited by this paper
32. PDE4: A Novel Target in the Treatment of Chronic Obstructive Pulmonary Disease · Joel Michalski · 2011 · 79 citations · Cited by this paper
33. Informing Healthcare Decisions with Observational Research Assessing Causal Effect. An Official American Thoracic Society Research Statement · Andrea S. Gershon · 2021 · 74 citations · Cited by this paper
34. Long-term azithromycin therapy to reduce acute exacerbations in patients with severe chronic obstructive pulmonary disease · Nafiseh Naderi · 2018 · 42 citations · Cited by this paper
35. Management of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Hospitalized Patients From Admission to Discharge: A Comprehensive Review of Therapeutic Interventions · Khizar Scheeraz Khan · 2023 · 28 citations · Cited by this paper
36. Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry · Spyridon Fortis · 2020 · 18 citations · Cited by this paper
37. Eligibility of patients with chronic obstructive pulmonary disease for inclusion in randomised control trials investigating triple therapy: a study using routinely collected data · Hannah R. Whittaker · 2024 · 16 citations · Cited by this paper
38. Comparative Effectiveness of Roflumilast and Azithromycin for the Treatment of Chronic Obstructive Pulmonary Disease · Jenny Lam · 2021 · 8 citations · Cited by this paper
39. Understanding the People Excluded from Chronic Obstructive Pulmonary Disease Clinical Trials · Jamuna K. Krishnan · 2022 · 7 citations · Cited by this paper

Source: OpenAlex (CC0)